Tarceva (erlotinib)

September 26, 2008 by RecallAware
Filed under: Medicine 

Cases of hepatic failure and hepatorenal syndrome, including fatalities, have been reported during use of Tarceva, particularly in patients with baseline hepatic impairment.

Source:Full Article

Tags:

Comments

Readers of this site appreciate your comments

You must be logged in to post a comment.

References and links to other sites are provided as a courtesy. The recall and safety information provided here is based entirely on manufacturers' and regulatory agencies' press release or other public information. We make no other representations about the accuracy or timeliness of this information